Topic: New Insights in Liver Cancer

Download All Articles

A special issue of Hepatoma Research  (Print ISSN:2394-5079; Online ISSN:2454-2520).

Deadline for manuscript submissions: 30 Sep 2018

Share This Special Issue

Guest Editor(s)

  • Clara Balsano, MD
    Internal Medicine (MED 09), Department of Life, Health and Environmental Sciences (MESVA), University of L'Aquila, L'Aquila, Italy.


Submission Information:

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 30 Sep, 2018
Contacts: Siqi Li, Assistant Editor,

Published Articles Download All Articles
  • Fat and hepatocellular carcinoma

    Clara Balsano , Cristiana Porcu , Silvia Sideri , Simona Tavolaro
    Obesity and diabetes are associated with the onset of hepatocellular carcinoma (HCC). These two illnesses correlate also with the development of non-alcoholic fatty liver disease (NAFLD). Currently, NAFL is considered the leading form of chronic liver disease in the Western industrialized countries. Insulin resistance is the common pathogenic factor among these three pathologies. NAFL is characterized by fat accumulation in the liver that involves greater than 5% of the liver parenchyma with no evidence of hepatocyte injury. However, NAFL may progress toward non-alcoholic steatohepatitis... Read more
    This article belongs to the Special Issue New Insights in Liver Cancer
    Hepatoma Res 2018;4:38. | doi:10.20517/2394-5079.2018.51
    Published on: 25 Jul 2018  | Viewed:1249  | Downloaded:139
    +HTML| PDF
  • Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma

    Andrea Martini , Patrizia Pontisso
    Hepatocellular carcinoma (HCC) is one of the most relevant sanitary problems for its prevalence and poor prognosis. This tumor is characterized by highly heterogeneous features, both at clinical and molecular level. SerpinB3 (squamous cell carcinoma antigen-1 or SCCA1) is a serine-protease inhibitor that protects cells from oxidative stress conditions, but in chronic liver damage it may lead to HCC through different strategies, including inhibition of apoptosis, induction of epithelial to mesenchymal transition, cell proliferation and invasiveness. Mechanisms of tumor growth promotion... Read more
    This article belongs to the Special Issue New Insights in Liver Cancer
    Hepatoma Res 2018;4:28. | doi:10.20517/2394-5079.2018.50
    Published on: 29 Jun 2018  | Viewed:339  | Downloaded:29
    +HTML| PDF
  • HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: still an issue?

    Francesco Paolo Russo , Martina Tessari , Angela Imondi , Erica Nicola Lynch , Fabio Farinati
    New regimens with direct-acting antivirals (DAAs) agents have changed both efficacy and safety of hepatitis C virus (HCV)-treatment, as almost all patients can be treated and cured at any stage of liver disease. The rates of sustained virological response to currently available combinations exceed 95% in real-life practice. However, conflicting results have been produced on the occurrence/recurrence of hepatocellular carcinoma (HCC) in patients with HCV-associated cirrhosis treated with DAAs. In this review we analyse the data available in the literature in order to elucidate the impact of... Read more
    This article belongs to the Special Issue New Insights in Liver Cancer
    Hepatoma Res 2018;4:25. | doi:10.20517/2394-5079.2018.52
    Published on: 27 Jun 2018  | Viewed:676  | Downloaded:86
    +HTML| PDF
  • Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor

    Gabriele Missale , Elisabetta Cariani
    The multiplicity and phenotype of intratumoral immune infiltrate have been shown to influence the clinical outcome of hepatocellular carcinoma (HCC), thus providing a strong rationale to therapeutic interventions aimed at restoring the dysfunctional immune response against the tumor. Improving the knowledge of the complex interactions between transformed hepatocytes, nonparenchymal resident cells, and infiltrating immune cells (characterizing the HCC microenvironment) will be instrumental to increase the success rate of existing immunotherapeutic strategies and to identify new potential... Read more
    This article belongs to the Special Issue New Insights in Liver Cancer
    Hepatoma Res 2018;4:22. | doi:10.20517/2394-5079.2018.72
    Published on: 25 Jun 2018  | Viewed:604  | Downloaded:54
    +HTML| PDF
  • Intrahepatic cholangiocarcinoma: review and update

    Vincenzo Cardinale , Maria Consiglia Bragazzi , Guido Carpino , Sabina Di Matteo , Diletta Overi , Lorenzo Nevi , Eugenio Gaudio , Domenico Alvaro
    Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies that could develop at any level from the biliary tree. CCA is currently classified into intrahepatic (iCCA), perihilar and distal on the basis of its anatomical location. Of note, these three CCA subtypes have common features but also important inter-tumor and intra-tumor differences that can affect the pathogenesis and outcome. A unique feature of iCCA is that it recognizes as origin tissues, the hepatic parenchyma or large intrahepatic and extrahepatic bile ducts, which are furnished by two distinct stem cell niches, the... Read more
    This article belongs to the Special Issue New Insights in Liver Cancer
    Hepatoma Res 2018;4:20. | doi:10.20517/2394-5079.2018.46
    Published on: 19 Jun 2018  | Viewed:1200  | Downloaded:169
    +HTML| PDF
Hepatoma Research ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)
Copyright © 2018 OAE Publishing Inc. All Rights Reserved.